Microvascular Dysfunction as a Bridge between Chronic Obstructive Pulmonary Disease and Ischemic Events :...

Area of Science:

• Cardiovascular Medicine
• Pulmonology
• Pathophysiology

Background:

• Chronic obstructive pulmonary disease (COPD) is increasingly recognized as a systemic illness, not just a lung disorder.
• COPD patients exhibit elevated risks for ischemic events like myocardial infarction and stroke, even when accounting for shared risk factors.
• The precise mechanisms linking pulmonary dysfunction to these vascular comorbidities remain under investigation.

Purpose of the Study:

• To review current evidence linking COPD to microvascular dysfunction (MVD).
• To propose MVD as a key intermediary mechanism connecting COPD to ischemic events.
• To explore therapeutic strategies targeting endothelial health in COPD patients.

Main Methods:

• Synthesis of findings from molecular, imaging, and epidemiological studies.
• Examination of the role of systemic inflammation and oxidative stress.
• Review of therapeutic interventions focused on endothelial function.

Main Results:

• Microvascular dysfunction (MVD), involving endothelial injury and impaired vasoreactivity, is implicated in COPD's vascular complications.
• Systemic inflammation and oxidative stress originating in the lungs contribute to vascular damage.
• Evidence supports MVD as a mechanistic bridge between COPD and increased ischemic risk.

Conclusions:

• Microvascular dysfunction (MVD) is a critical link between COPD and ischemic events.
• Therapeutic strategies targeting endothelial health may offer new avenues for intervention.
• An integrated clinical approach addressing both pulmonary and vascular health is essential for COPD management.